135 related articles for article (PubMed ID: 25787266)
1. The Impact of Implementation Fidelity on Mortality Under a CD4-Stratified Timing Strategy for Antiretroviral Therapy in Patients With Tuberculosis.
Patel MR; Westreich D; Yotebieng M; Nana M; Eron JJ; Behets F; Van Rie A
Am J Epidemiol; 2015 May; 181(9):714-22. PubMed ID: 25787266
[TBL] [Abstract][Full Text] [Related]
2. Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.
Van Rie A; Patel MR; Nana M; Vanden Driessche K; Tabala M; Yotebieng M; Behets F
J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e110-7. PubMed ID: 24091692
[TBL] [Abstract][Full Text] [Related]
3. Delayed antiretroviral therapy despite integrated treatment for tuberculosis and HIV infection.
Patel MR; Nana M; Yotebieng M; Tabala M; Behets F; Van Rie A
Int J Tuberc Lung Dis; 2014 Jun; 18(6):694-9. PubMed ID: 24903941
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level.
Patel MR; Yotebieng M; Behets F; Vanden Driessche K; Nana M; Van Rie A
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1206-11. PubMed ID: 23827656
[TBL] [Abstract][Full Text] [Related]
5. Mortality among tuberculosis patients in the Democratic Republic of Congo.
Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
[TBL] [Abstract][Full Text] [Related]
6. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE;
N Engl J Med; 2011 Oct; 365(16):1471-81. PubMed ID: 22010913
[TBL] [Abstract][Full Text] [Related]
7. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
Havlir DV; Kendall MA; Ive P; Kumwenda J; Swindells S; Qasba SS; Luetkemeyer AF; Hogg E; Rooney JF; Wu X; Hosseinipour MC; Lalloo U; Veloso VG; Some FF; Kumarasamy N; Padayatchi N; Santos BR; Reid S; Hakim J; Mohapi L; Mugyenyi P; Sanchez J; Lama JR; Pape JW; Sanchez A; Asmelash A; Moko E; Sawe F; Andersen J; Sanne I;
N Engl J Med; 2011 Oct; 365(16):1482-91. PubMed ID: 22010914
[TBL] [Abstract][Full Text] [Related]
8. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
9. Impact of the implementation of new guidelines on the management of patients with HIV infection at an advanced HIV clinic in Kinshasa, Democratic Republic of Congo (DRC).
Mangana F; Massaquoi LD; Moudachirou R; Harrison R; Kaluangila T; Mucinya G; Ntabugi N; Van Cutsem G; Burton R; Isaakidis P
BMC Infect Dis; 2020 Oct; 20(1):734. PubMed ID: 33028245
[TBL] [Abstract][Full Text] [Related]
10. Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS.
Vijayan T; Semitala FC; Matsiko N; Elyanu P; Namusobya J; Havlir DV; Kamya M; Geng EH
Clin Infect Dis; 2013 Dec; 57(12):1766-72. PubMed ID: 24065326
[TBL] [Abstract][Full Text] [Related]
11. CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.
Collins SE; Jean Juste MA; Koenig SP; Secours R; Ocheretina O; Bernard D; Riviere C; Calnan M; Dunning A; Hurtado Rúa SM; Johnson WD; Pape JW; Fitzgerald DW; Severe P
Int J Tuberc Lung Dis; 2015 Jan; 19(1):50-7. PubMed ID: 25519790
[TBL] [Abstract][Full Text] [Related]
12. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.
Alvarez-Uria G; Pakam R; Midde M; Naik PK
J Int AIDS Soc; 2014; 17(1):19251. PubMed ID: 25499123
[TBL] [Abstract][Full Text] [Related]
13. Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo.
Callens SF; Shabani N; Lusiama J; Lelo P; Kitetele F; Colebunders R; Gizlice Z; Edmonds A; Van Rie A; Behets F;
Pediatr Infect Dis J; 2009 Jan; 28(1):35-40. PubMed ID: 19057457
[TBL] [Abstract][Full Text] [Related]
14. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
Bwire R; Nagelkerke NJ; Borgdorff MW
Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
[TBL] [Abstract][Full Text] [Related]
15. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
Stringer JS; Zulu I; Levy J; Stringer EM; Mwango A; Chi BH; Mtonga V; Reid S; Cantrell RA; Bulterys M; Saag MS; Marlink RG; Mwinga A; Ellerbrock TV; Sinkala M
JAMA; 2006 Aug; 296(7):782-93. PubMed ID: 16905784
[TBL] [Abstract][Full Text] [Related]
16. Early Antiretroviral Therapy Initiation and Mortality Among Infants Diagnosed With HIV in the First 12 Weeks of Life: Experiences From Kinshasa, DR Congo and Blantyre, Malawi.
Sheahan A; Feinstein L; Dube Q; Edmonds A; Chirambo CM; Smith E; Behets F; Heyderman R; Van Rie A
Pediatr Infect Dis J; 2017 Jul; 36(7):654-658. PubMed ID: 28060044
[TBL] [Abstract][Full Text] [Related]
17. [Simultaneous treatment of HIV and tuberculosis is possible and necessary].
von der Maase S; Gerstoft J; Wejse C
Ugeskr Laeger; 2014 Feb; 176(6A):V03130163. PubMed ID: 25347439
[TBL] [Abstract][Full Text] [Related]
18. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
19. The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.
Peltzer K; Ramlagan S; Khan MS; Gaede B
SAHARA J; 2011; 8(4):179-86. PubMed ID: 23236959
[TBL] [Abstract][Full Text] [Related]
20. Impact of Moringa oleifera lam. Leaf powder supplementation versus nutritional counseling on the body mass index and immune response of HIV patients on antiretroviral therapy: a single-blind randomized control trial.
Tshingani K; Donnen P; Mukumbi H; Duez P; Dramaix-Wilmet M
BMC Complement Altern Med; 2017 Aug; 17(1):420. PubMed ID: 28830411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
